The Journal of Organic Chemistry · 2002 · 23 citations · 18 references
MedicineMedicinal ChemistryPharmacologyDrug DesignDrug DiscoveryMolecular PharmacologyCannabinoid PharmacologyLigand BindingCannabinoid AgonistsCannabinoid Receptor PharmacologyCannabinoid Structure-activity RelationshipsCovalent Chemical ProbesG-protein-coupled ReceptorsQuinone MethidesStructure-based Ligand Design
The main psychoactive constituent of marijuana, (-)-Delta(9)-tetrahydrocannabinol, produces most of its physiological effects by interacting with the CB1 cannabinoid receptor, a membrane protein belonging to the large superfamily of G-protein coupled receptors. The 3-D structure of the receptor binding site is of value in the design of novel medications for a variety of therapeutic indications. To obtain information on the amino acid residues associated with this binding site, we have designed and synthesized a cannabinergic CB1 ligand prototype carrying an electrophilic isothiocyanato group capable of reacting covalently with amino acid residues bearing thiol or unprotonated amino groups. The ligand also incorporates an iodide atom, which can serve as a high-activity radiolabel. The key step in our synthesis involves a rapid intramolecular Diels-Alder reaction of a transiently formed o-quinone methide, which proceeds stereospecifically with the formation of the tricyclic cannabinoid template. Introduction of the iodo group is the last step in the sequence and is compatible with the use of (125)I-radiolabel.
18
Crystal Structure of Rhodopsin: A G Protein-Coupled Receptor
Krzysztof Palczewski, Takashi Kumasaka, Tetsuya Hori et al. · Science · 2000 · 5.6K citations
Endocannabinoids control spasticity in a multiple sclerosis model
David Baker, Gareth Pryce, J. Ludovic Croxford et al. · The FASEB Journal · 2000 · 381 citations
Medicine, Neurology, Pharmacology +17
Herbert C. Brown, S. Krishnamurthy · Journal of the American Chemical Society · 1972 · 292 citations